Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07692789 · ClinicalTrials.gov registry record · NA
Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems
A NA study, sponsored by Ohio State University.
- Not yet
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT07692789: Clinical Trial NA study, sponsored by Ohio State University.
NCT07692789 is a NA study that has not yet begun recruiting, run by Ohio State University. The registered enrollment target is 162 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07692789, a NA study, has not yet begun recruiting, sponsored by Ohio State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the rate of successful urodynamics procedure completion between a prospective intervention group and a historical control group after a pre-procedure patient reminder system to determine whether the intervention improves procedural success and healthcare delivery. The impact of the reminder system on patient satisfaction, preparedness, and anxiety will also be evaluated.
Primary Outcome
Completion failure is defined as a uroflow less than 150 mL
Interventions
- OTHER Patient reminder system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
| Phase | NA |
What is known before NCT07692789 opens enrollment
NCT07692789 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient reminder system is the first listed.
NCT07692789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07692789 about?
NCT07692789 is a clinical study titled "Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems". The purpose of this study is to compare the rate of successful urodynamics procedure completion between a prospective intervention group and a historical control group after a pre-procedure patient reminder system to determine whether the intervention improves procedural success and healthcare deliv...
What is the current status of trial NCT07692789?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2026-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07692789?
The interventions under investigation include: Patient reminder system (OTHER).
Who is sponsoring clinical trial NCT07692789?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07692789's enrollment target sits among peer trials
162 627th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia